Epilepsy has long been treated, genetically speaking, as a single-gene problem: find the one broken gene, and you have your diagnosis. A study from Baylor College of Medicine and the Duncan Neurological Research Institute at Texas Children's Hospital, published in the Journal of Clinical Investigation, challenges that assumption. The team identified a biological pathway that triggers seizures when disrupted, and showed that the disruption can come from specific combinations of two - and possibly more - defective genes acting together.
That distinction matters because of a stubborn gap in epilepsy care. Scientists have catalogued more than 1,000 genes that can individually cause epilepsy when they go wrong, yet more than half of patients whose epilepsy is suspected to be genetic never receive a genetic diagnosis. If harmful gene pairs are part of the explanation, standard testing that hunts for a single culprit variant would systematically miss them.
Epilepsy affects roughly 50 million people worldwide, or about 1 in 130, according to the researchers. Dr. Hugo Bellen, the study's corresponding author and Distinguished Service Professor of molecular and human genetics at Baylor, holds the chair in neurogenetics at the Duncan NRI. The authors say the work could sharpen genetic diagnosis and open treatment avenues for cases that are currently unsolved or resistant to available drugs.
The practical payoff will depend on whether diagnostic labs can begin looking for these combinations rather than single variants, and on how many unexplained cases turn out to fit the pattern. For families who have gone through genetic testing and come away with no answer, the finding offers a plausible reason why - and a direction for the next round of investigation.